Robuta

https://www.ajmc.com/view/spotlight-cemiplimab-shows-promising-results-in-adjuvant-treatment-for-cscc
Cemiplimab significantly enhances disease-free survival in high-risk cSCC patients, reducing recurrence and metastasis risks, according to findings presented...
adjuvant treatmentspotlightcemiplimabshowsresults